Long-term effect of alprenolol as antihypertensive agent.
D000328:Adult; D000402:Airway Obstruction / Q000139:chemically induced; D000526:Alprenolol / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002752:Chlorthalidone / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D003864:Depression, Chemical; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008875:Middle Aged; D010919:Placebos; D011433:Propranolol / Q000627:therapeutic use; D013268:Stimulation, Chemical; D013997:Time Factors; D014527:Uric Acid / Q000097:blood
D003692:Delayed-Action Preparations; D010919:Placebos; D014527:Uric Acid; D000526:Alprenolol; D011433:Propranolol; D002752:Chlorthalidone